Tag Archives: ALNY

Best Biotech Stocks To Watch For 2019

Introduction

Roche ADRs (OTCQX:RHHBY) remain in a downtrend even as the company has increased its guidance, following detailed but interim Q1 results (no EPS reported), to modest organic growth this year, but high-single-digit growth including the effects of last December’s US tax legislation. Coming into the important ASCO (oncology) meeting this weekend, this article provides an....More>>>

Top 5 Biotech Stocks To Own For 2019

When biotech investors talk about the future of DNA sequencing, they inevitably focus on industry leader Illumina (NASDAQ:ILMN). But when biotech researchers talk about the future of DNA sequencing, the conversation almost always centers on privately held Oxford Nanopore Technologies, which is developing a new approach to reading genetic code called nanopore sequencing. The excitement isn’t....More>>>

Hot Biotech Stocks To Invest In Right Now

Reata Pharmaceuticals (RETA) is a clinical-stage biotechnology company specializing in drugs that affect mitochondria-related diseases. Its lead candidate is for PAH (pulmonary arterial hypertension) resulting from connective tissue disease.

Reata came up in a screening I did of the new additions to the Nasdaq Biotechnology Index, which is used as a basis for the iShares Nasdaq Biotechnology....More>>>

Hot Biotech Stocks To Own For 2019

Shares of Spark Therapeutics (NASDAQ:ONCE) have seen a nice bounce recently, having risen by 30% since late February. It looks like my “buy the dip” piece in late November was followed by a much larger “dip” than I was expecting (Note: This was an unexpected event and great example of how biotech is a minefield).

Figure 1: ONCE daily advanced chart (Source: Finviz....More>>>

Top 10 Biotech Stocks For 2019

The following stocks were moving the Manufacturing sector today.

Some of the biggest gainers among Manufacturing stocks include:

Diffusion Pharmaceuticals Inc (DFFN): DFFN stock is up 47.73% today. Kura Oncology Cmn (KURA): KURA stock is up 15.46% today. Modine Manufacturing Company (MOD): MOD stock is up 9.96% today. Stellar Biotch Cm ST (SBOT): SBOT stock is up 10.1% today. Aeglea....More>>>

Hot Biotech Stocks To Watch For 2019

I constantly see people rise in life who are not the smartest, sometimes not even the most diligent, but they are learning machines. They go to bed every night a little wiser than they were when they got up and boy does that help, particularly when you have a long run ahead of you. – Charlie Munger

Trading Analytics

Welcome to this edition of Integrated BioSci Rounds Report....More>>>

Top 5 Biotech Stocks To Buy Right Now

Kodak is moving from cameras to crypto in a move likely to be viewed as a picture-perfect example of bitcoin mania.

The century-old camera brand said Tuesday it is investing in blockchain technology and plans to launch a “photo-centric cryptocurrency” called KODAKCoin.

Kodak (KODK)’s stock surged as much as 125% in trading after the announcement.

With....More>>>

Top 10 Biotech Stocks To Watch For 2018

What happened

Shares ofSangamo Therapeutics (NASDAQ:SGMO) are down 10% as of 1:28 p.m. EDT after the biotech announcedfirst-quarter results this morning, although there doesn’t seem to be any negative news in the release that would justify a double-digit decline.

Perhaps it’s the lack of something extra in the update that has short-term investors hitting the sell button.....More>>>

Top 5 Biotech Stocks To Invest In 2018

Baltimore, MD, based Investment company Rothschild Capital Partners, LLC buys SPDR Select Sector Fund – Financial, SPDR S&P Regional Banking, SPDR Select Sector Fund – Health Care, SPDR Series Trust S&P Biotech, Burlington Stores Inc, US Foods Holding Corp, SPDR Select Sector Fund – Industrial, Dollar Tree Inc, SVB Financial Group, SPDR S&P Retail, sells Celgene Corp,....More>>>

Top 5 Biotech Stocks To Buy Right Now

Momenta Pharmaceuticals (NASDAQ:MNTA) issued its quarterly earnings results on Tuesday. The biotechnology company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.48) by ($0.15), Morningstar.com reports. The firm had revenue of $4.85 million for the quarter, compared to the consensus estimate of $15.63 million. Momenta Pharmaceuticals....More>>>